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Abstract
Introduction: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited 
pathology that can increase the risk of sudden death. Current task force criteria for 
echocardiographic diagnosis do not include new, regional assessment tools which may be 
relevant in a phenotypically diverse disease. We adopted a systematic review and  
meta-analysis approach to highlight echocardiographic indices that differentiated ARVC 
patients and healthy controls.
Methods: Data was extracted and analysed from prospective trials that employed a  
case–control design meeting strict inclusion and exclusion as well as a priori quality 
criteria. Structural indices included proximal RV outflow tract (RVOT1) and RV diastolic area 
(RVDarea). Functional indices included RV fractional area change (RVFAC), tricuspid annular 
systolic excursion (TAPSE), peak systolic and early diastolic myocardial velocities (S′ and E′, 
respectively) and myocardial strain.
Results: Patients with ARVC had larger RVOT1 (mean ± s.d.; 34 vs 28 mm, P < 0.001) and 
RVDarea (23 vs 18 cm2, P < 0.001) compared with healthy controls. ARVC patients also 
had lower RVFAC (38 vs 46%, P < 0.001), TAPSE (17 vs 23 mm, P < 0.001), S′ (9 vs 12 cm/s, 
P < 0.001), E′ (9 vs 13 cm/s, P < 0.001) and myocardial strain (−17 vs −30%, P < 0.001).
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Conclusion: The data from this meta-analysis support current task force criteria for the 
diagnosis of ARVC. In addition, other RV measures that reflect the complex geometry 
and function in ARVC clearly differentiated between ARVC and healthy controls and may 
provide additional diagnostic and management value. We recommend that future working 
groups consider this data when proposing new/revised criteria for the echocardiographic 
diagnosis of ARVC.
Introduction
Arrhythmogenic right ventricular cardiomyopathy/
dysplasia (ARVC/D) is a genetic disease that is characterized 
by (i) fibro-fatty replacement, (ii) myocardial atrophy, (iii) 
fibrosis, and (iv) chamber dilation and aneurysms (1). 
Pathological changes occur predominantly in the right 
ventricle (RV) and culminate in heart failure (1, 2, 3) with 
sudden cardiac death (SCD), a common outcome (1, 2, 4). 
It is clearly important to identify those with ARVC as early 
as possible in order to treat and reduce health risk.
The prevalence of ARVC in the general population has 
been reported to be 1:5000, affecting men more frequently 
than women with a ratio of 3:1 (5, 6). The accuracy of 
available prevalence data is, however, still debated largely 
due to the complexities in diagnosing the disease (7). 
Currently, the diagnosis of ARVC can be established 
using a set of major and minor criteria proposed by an 
International Task Force in 1994 and updated/revised in 
2010 (8, 9). The structural and functional assessment of 
the RV, using transthoracic echocardiography, is central 
to ARVC diagnosis in the original and updated task 
force criteria. Although the recent task force revision 
has improved specificity of diagnosis, there has been 
little impact upon diagnostic sensitivity (3) which 
may be due to the reliance on only two RV anatomical 
measures (the RV outflow tract from a parasternal long 
(RVOTPLAX) and short axis (RVOT1)) and one functional 
measure (RV fractional area change (RVFAC)). It is likely 
that these parameters do not fully reflect the complexities 
of RV structure and function specifically in ARVC where 
phenotype expression is variable (1, 7) and regional 
changes in structure and function are likely. A more 
comprehensive echocardiographic assessment of the RV 
in ARVC patients is warranted (10) in order to potentially 
improve diagnostic accuracy.
The use of techniques, such as tissue Doppler imaging 
and speckle tracking echocardiography (STE), that 
quantifies regional myocardial deformation/strain have 
the potential to provide new information in ARVC (11, 
12, 13). Likely, due to the low prevalence of the disease, 
these studies are often based on relatively small sample 
sizes that restrict generalizability to all populations 
(13, 14, 15). A qualitative assessment of recent research in 
this area highlights limitations such as a lack of a matched 
control group and variability in echocardiographic tools 
and techniques. To determine if new echocardiographic 
data may provide additional diagnostic options this study 
employed a systematic review (with clear quality control 
and inclusion/exclusion criteria) alongside a meta-
analysis to determine which RV structural and functional 
parameters are different between patients with ARVC and 
matched, healthy control subjects.
Methods
Search criteria and processes
Study selection We identified all transthoracic 
echocardiographic studies that examined ARVC patients 
and recorded parameters related to RV structure and/or 
function published between 1990 and 2015 and written 
with an English language abstract. Electronic search 
engines used included Pub Med; Discover; Scopus; Web 
of Science; Cochrane, and we employed relevant Medical 
Subject Headings and keywords related to our search. The 
following search keyword strings were used:
•	 Echocardiography AND (ARVC OR ARVD) AND 
(arrhythmogenic right ventricular cardiomyopathy OR 
arrhythmogenic right ventricular dysplasia).
The initial search identified 966 records. The first level 
of filtration included screening of titles, authors and 
abstracts and was completed independently by two 
reviewers (M Q, D O). In the case of discrepancy between 
reviewers a third independent reviewer was invited to 
feedback and subsequently a final review meeting was 
undertaken to determine a consensus opinion. Initial 
filtration removed case studies, duplications, reviews, 
animal studies as well as comparing the abstract against 
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the following inclusion criteria: (i) genotype-positive 
ARVC patients, (ii) age range 16–65 years, and (iii) all 
participants had echocardiography and reported RV 
parameters, (16), which matched description of the task 
force criteria (8, 9). This filtration identified 45 studies 
for complete evaluation of the full research paper by the 
same two independent reviewers. These 45 papers were 
also subjected to a quality assessment using a checklist 
modified by the research team from the PRISMA (17) 
and STROBE (18) statements, to develop the systematic 
evaluation of the quality of observational studies. A 
threshold of 40% adherence of the quality criteria 
checklist was adopted. From the 45 papers identified 
19 were excluded based on incomplete data sets with 
abstract only, 12 due to lack of including both an ARVC 
and a control groups, 2 non-English manuscripts that 
were missed by the original filtration process, and 2 with 
poor overall quality scores. The remaining 10 papers were 
subject to full data extraction and meta-analysis. The 
overall filtration process is detailed in Fig. 1.
Data extraction Data extraction was undertaken 
by two investigators (M Q, D O) and where present 
included data for the following RV structural parameters: 
the proximal outflow tract from a parasternal short axis 
(RVOT1), distal outflow tract from a parasternal short 
axis (RVOT2), proximal outflow tract from a parasternal 
long axis (RVOTplax), basal inflow diameter (RVD1), mid-
inflow diameter (RVD2), base-to-apex length (RVD3) and 
RV end-diastolic area (RVDarea). In addition, the following 
functional RV parameters were extracted: fractional 
area change (RVFAC), tricuspid annular plane systolic 
excursion (TAPSE), peak systolic myocardial velocity 
(RVS’), peak early diastolic myocardial velocity (RVE′), 
peak late diastolic myocardial velocity (RVA′), peak global 
longitudinal strain (RV ε) and peak global systolic strain 
rate (RVSRS′). Demographic data of age, body surface area 
and body mass index were also collected. All relevant 
data were extracted directly from the 10 papers into a 
spreadsheet (Excel 2010, Microsoft). Control and ARVC 
groups were coded discretely for each study.
Statistical analysis
Continuous data for RV morphology and functional data 
were recorded as group mean ± s.d. for each study. Due 
to insufficient study numbers, RVOT2, RVOTplax, RVD1, 
RVD2, RVD3, RVA′ and RVSRS′ were not included in the 
meta-analysis but instead were assessed qualitatively. All 
statistical analysis was carried out with comprehensive 
meta-analysis software Version 3.3.070 (Biostat, 
Englewood, NJ, USA). A random effect meta-analysis 
model was used to quantify the weighted mean difference 
(WMD) (i.e. difference in means) and 95% confidence 
intervals of ARVC group compared with control group 
allowing the production of parameter-specific forest plots. 
To estimate or quantify the impact of between-study 
variation (heterogeneity) of the studies, I2 and τ2 were used 
(19). Cut-off values were established to provide clinically 
meaningful data utilizing the pooled range data. Where 
there was overlap between groups a consensus approach 
was used which drew on the expertise of the working 
group. This is common practice in guideline development 
where ambiguous or inconclusive findings are evident 
(20). No ethical clearance required for this meta-analysis, 
all studies used have been previously published.
Results
Baseline characteristics of the ARVC patients are 
summarized in Table  1 and characteristics of included 
studies in Table 2. The pooled mean data for the specific 
echocardiographic parameters, cut-off values and an 
assessment of heterogeneity are presented in Table  3. 
Figure 1
Flow diagram of literature filtration process.
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The  meta-analysis highlighted a significantly larger 
RVOT1 (P < 0.00, 95% CI: 3.649–7.112 mm) and RVDarea 
(P < 0.00, 95% CI: 2.607–7.060 cm2) in the ARVC group 
compared with controls.
RV functional data was significantly lower for RV ε 
(P < 0.00, 95% CI: 8–15%), RVFAC (P < 0.00, 95% CI: −11 
to −6%), TAPSE (P < 0.00, 95% CI: −5.488 to −4 mm), RVS′ 
(P < 0.00, 95% CI: −3 to −2 cm/s) and RVE′ (P < 0.00, 95% 
CI: −5 to −2 cm/s) (Table  1). Exemplar forest plots are 
presented in Fig. 2.
Discussion
The main findings from this systematic review and meta-
analysis are (i) there are significant differences in a range 
of structural and functional echocardiographic parameters 
between ARVC patients and healthy, control participants, 
and (ii) data from tissue Doppler and STE may represent 
useful additional tools when attempting to differentiate 
RV phenotype of ARVC patients from healthy controls.
Right ventricular structure
ARVC is a genetic disease that may present with atrophy 
of the RV myocardium, leading to aneurysmal dilation 
and wall motion abnormalities (21, 22). Although 
this is a typical morphological pattern, the genotype–
phenotype expression is variable often leading to 
heterogeneous structural adaptation (23, 24). That aside, 
a ‘triangle of dysplasia’ in terms of both structure and 
function is frequently described which leads to localized 
dilation and dysfunction at the inflow tract (sinus), 
apex and RVOT (25, 26) or infundibulum (RVOT2) (27). 
Table 2 Baseline characteristics.
Study Syncope Palpitations
Family 
history Anti- arrhythmic Beta- blockers Defibrillator
RV systolic 
pressure 
(mmHg)
Ventricular 
tachycardia
Ventricular 
arrhythmias Other
(13) 10 3 11 2 NR 9 NR 4
(46) 11 16 NR NR 20 21 30 ± 18 NR NR NR
(14) 3 9 4 3 5 1 1a NR NR NR
(38) NR NR 17 NR NR NR NR 7 28 NR
(4) 13 18 NR NR NR 45 29 ± 6 14 NR 9
(34) 3 NR 2 17 12 NR 22 NR
(15) NR NR NR NR 14 11 NR NR NR NR
(36) NR NR NR 13 NR 9 NR NR NR NR
(3) NR NR NR Drug therapy 
was not 
discontinued
NR NR NR NR NR NR
(46) NR NR NR NR NR NR NR NR NR NR
aMean RV systolic pressure was within normal range in both groups with only a single patient with ARVD demonstrating significant tricuspid regurgitation.
NR, not reported.
Table 3 Data are pooled mean estimates (95% CI), [number of studies, number of participants].
Parameters ARVC Control Cut-off
Difference in mean 
(95% CI)
Heterogeneity test
Hetero-
geneity I2 (%)
P 
value
RVOT1 (mm) 34 (30–38) [n = 5; 166] 28 (26–30) [n = 5; 155]a 31 5.4 (3.6–7.1) 3 66 0.02
RVDarea (cm2) 23 (19–26) [n = 4; 136] 18 (17–19) [n = 4; 119]a 20 4.8 (2.6–7.1) 3.7 75 0.007
RVFAC (%) 37.6 (33.4–41.9) [n = 7; 195] 45.9 (42.4–49.5) [n = 7; 217]a 42 −8.1 (−10.6 to −5.6) 0.01 64 0.012
TAPSE (mm) 18 (16–20) [n= 6; 125] 23 (20–25) [n = 6; 179]a 20 −4.7 (−5.5 to −3.9) 0 51 0.444
RVS′ (cm/s) 9 (8–10) [n = 8; 192] 12 (10–13) [n = 8; 229]a 10 −2.7 (−3.2 to −2.2) 0.2 37 0.135
RVE′ (cm/s) 9 (7–11) [n = 4; 94] 13 (10–16) [n = 4; 120]a 10 −3.8 (−5.2 to −2.4) 1.42 69 0.021
RV strain (%) −17 (−21 to −13) [n = 5; 154] −29 (−31 to −27) [n = 5; 157]a −21 11.5 (7.7−15.3) 15 83 0
aP < 0.001 vs ARVC.
RV proximal outflow (RVOT1), RV end-diastolic area (RVDarea), RV fractional area change (RVFAC), tricuspid annular plane systolic excursion (TAPSE),  
RV peak systolic myocardial velocity (RVS'), RV peak early diastolic myocardial velocity (RVE') and RV global longitudinal strain (RV ε).
Heterogeneity evaluation: (1) I2 = 25% low heterogeneity, 50% moderate heterogeneity, 50–75% high heterogeneity, (2) P < 0.1 for statistical 
significance, (3) τ2 > 1, statistical significant for heterogeneity.
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Apical involvement is often seen in more advanced 
stages of the disease (25, 26) and the RVOT is the most 
common starting point of non-ischemic ventricular 
arrhythmias (28). This leads to the RVOT and/or inflow 
of the RV being the primary focus for early detection and 
subsequent serial assessment (25).
The current echocardiographic component of 
the task force criteria focuses on determining any 
localized structural dilatation of the outflow tract from 
either a short or long axis only. Data from the current 
systematic review and meta-analysis supports this. 
Interestingly, we present no overlap in RVOT1 between 
controls and ARVC patients with a cut-off of 30 mm 
clearly discriminating among the two groups. This cut-
off is lower than the current task force as well as the 
normative guidelines proposed by the American Society 
of Echocardiography (ASE) and raises the potential for 
a false-negative result when using existing criteria. Our 
data also demonstrate the importance of providing a 
holistic echocardiographic assessment of RV structure. 
The enlarged RVDarea seen in ARVC patients compared 
with the healthy controls suggests that chamber 
enlargement occurs at the inflow and apex also. The 
RVDarea cut-off based on our analysis is 19 cm2 but this 
is much lower than the normal value as proposed by 
the ASE. This may be a consequence of the specific 
age-matched control groups employed in the selected 
studies but clearly highlights the need for further 
clarification of normality.
Due to an insufficient number of studies reporting 
data for RVD1, we were unable to conduct a meaningful 
meta-analysis on this parameter. Qualitative assessment 
of those few studies that did implement this parameter 
provides additional support for RV enlargement in ARVC 
patients. It is apparent that these additional parameters 
should be considered in conjunction with the outflow 
tract in order to better detail RV morphology in patients 
with ARVC. This supports the fundamental pathological 
mechanisms of disease progression and the known 
distribution of fatty infiltration.
Right ventricular function
Both major and minor task force criteria for ARVC include 
the presence of regional wall motion abnormalities and/
or aneurysms (9). This clearly highlights the importance 
of functional RV wall degradation as part of the disease 
process. It is important to note that this is based on a 
subjective assessment, which is dependent on operator 
experience as well as image quality. Subtle changes in 
function may be missed, which could increase the risk 
of false-negative findings (29, 30). The current criteria 
also support an assessment of RVFAC, albeit this is 
only complementary and still must be in the presence 
of subjective regional wall motion abnormalities. Data 
from this meta-analysis provides additional insight 
including an RVFAC cut-off at 42% compared with 
33% in the task force criteria. Data from the matched 
controlled groups (n = 217), however, did not present 
with values below 42% raising the question of what is 
considered normal.
The complex nature of RV structure results in an 
equally complex ‘picture’ related to function. In healthy 
individuals, RV ejection is predominantly driven by a 
combination of stored kinetic mechanics derived from 
gravity and inspiration as well as longitudinal shortening 
(31). It has been demonstrated that this functional 
response may vary in different disease models in order to 
Figure 2
Exemplar forest plots for selected RV structural and functional parameters: RV fractional area change (RVFAC), tricuspid annular plane systolic excursion 
(TAPSE) and peak systolic myocardial velocity (RVS).
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compensate for changes in the structural and functional 
integrity of the RV (32, 33). In view of this a number 
of studies have assessed longitudinal RV function in 
ARVC utilizing TAPSE and TDI indices (1, 3, 15, 34). 
These data highlight the potential for detection in the 
early stages of the disease (1, 3) with a clear differential 
from healthy controls when using a 10 cm/s cut-off for 
systolic and diastolic myocardial tissue velocities. Aneq 
et  al. (36), demonstrated that both TAPSE and systolic 
myocardial velocities were strong diagnostic parameters 
for ARVC but further highlight the superiority of TDI 
particularly in detecting ARVC at its early stage (35, 36). 
Because of the inverse relationship between myocardial 
velocities and ageing process (37), the risk of a false-
positive result for ARVC would increase with advancing 
age and hence caution is required when interpreting in 
older age groups. Consequently, addition of parameters 
of intrinsic RV myocardial indices (TDI) provides 
additional diagnostic and/or monitoring benefit over 
and above RVFAC alone.
STE is a useful technique in the assessment of RV 
longitudinal function, with many studies demonstrating 
its value in variable disease states (3, 33, 38). In a study 
assessing the diagnostic utility of STE in ARVC, it was 
observed that RV ε was the strongest independent 
predictor of cMR-derived reduction in RV ejection 
fraction (39). In addition, Greiner et al. (33) demonstrated 
that when screening 94 patients (13 with ARVC), RV 
ε provided additional diagnostic accuracy such that 
reduced false-negative results were noted compared with 
the use of traditional echocardiographic parameters alone 
(33). In addition, both Yoerger et  al. (40) and Sarvari 
et al. (41) reported that RV ε has the highest sensitivity 
and specificity for the diagnosis of ARVC (40, 41). In the 
current meta-analysis, global systolic ε was reported as an 
average of either the free wall or the RV portion of the 
septum. There were no ARVC patients demonstrating a 
peak RV ε above −21% (n = 154); this is much lower than 
the currently accepted normal RV ε of −28% and lower 
than the control measure of −29%. On this basis, RV ε 
may well provide additional value in the diagnosis and 
management of patients with ARVC.
Clinical/imaging implications
There is ongoing debate in relation to the value of task 
force criteria in ARVC (42, 43). Some authors noted a 
significant reduction in the sensitivity of the revised 
task force criteria (3, 44) and it has been suggested 
that false-positive results may be a consequence of 
‘overinterpretation’ of subtle wall motion abnormalities 
(i.e. regional hypokinesia), which fall within the wide 
spectrum of normal RV function (3, 43). It is likely 
that the current task force criteria are limited by the 
number of measures undertaken. Additional parameters 
highlighted in this meta-analysis may improve diagnostic 
accuracy. As the current task force criteria is based on a 
multidisciplinary approach including clinical assessment, 
ECG, echocardiography, cMR, genetics and family history, 
any addition to the utilization of echocardiography needs 
to be made in this context and would likely add further 
corroborative information.
Limitations and future directions
First, it is important to note that due to the nature of 
this type of study there is the real risk of methodological 
and selection bias and specifically related to blinding or 
non-blinding of outcome assessment. The homogeneity 
and heterogeneity values presented here highlight that 
this is only a minor effect, however, it is important to 
acknowledge this potential limitation when interpreting 
the findings.
Due to the importance of establishing well-
defined quality criteria, as well as the variable methods 
employed by individual studies, some of the standard RV 
echocardiographic indices were not incorporated into the 
meta-analysis. Future work in this area should consider 
standardizing echocardiographic methods for assessment 
of structure and function. The model of this study does 
not support a sensitivity or specificity analysis; this would 
be a sensible next step with our proposed cut-off data.
We are now aware that ARVC is not just a disease of 
the RV. Recent studies have highlighted the gross and 
cellular impact on LV myocardial tissue (3, 21, 25, 45). 
Future work should continue to establish the extent and 
magnitude of LV involvement in ARVC and whether this 
can act as an important diagnostic or prognostic indicator.
STE offers the potential to provide regional peak 
and time-to-peak ε data of RV wall segments. However, 
few studies have attempted to incorporate this into 
their outcomes (3, 4, 14, 34, 46). Data for all RV wall 
segments (i.e. basal and apical) as well as the temporal 
relationship between RV structure and function could 
provide additional diagnostic value. At this stage, it 
is important to note that although most of the studies 
reviewed utilized GE systems to acquire and analyse STE 
some studies did use other manufacturers. The presence of 
inter-vendor variability has been previously documented 
(47). It is clear that further work is required to develop 
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consistent and valid RV ε data across platforms as well as 
further elucidating normality.
Conclusion
The data from this meta-analysis support task force 
criteria for the diagnosis of ARVC. In addition, the 
inclusion of other measures of RV structure that better 
reflect the complex geometry may provide diagnostic 
value. Specifically, the application of TDI and myocardial 
ε in combination with RVFAC and TAPSE may also provide 
additional value in this setting. We recommend that 
future working groups consider this data when proposing 
new/revised criteria for the echocardiographic diagnosis 
of ARVC.
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